Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Neoplasm Metastasis

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Neoplasm Metastasis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bida, B; Henker, C; Markwardt, J; Schlag, P1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Neoplasm Metastasis

ArticleYear
[Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
    Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:1

    Topics: Benzamides; Brain Neoplasms; Dopamine Antagonists; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Magnetic Resonance Imaging; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Pyrrolidines; Radionuclide Imaging; Skin Neoplasms; Tomography, X-Ray Computed

1997